HERON THERAPEUTICS INC HERON TH - stock earnings
0J4V.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -25.0 million USD | 31.4 million USD |
| 2023Q2 | -42.1 million USD | 31.8 million USD |
| 2023Q1 | -32.8 million USD | 29.6 million USD |
| 2022Q4 | -19.9 million USD | 30.0 million USD |
| 2021Q3 | -52.4 million USD | 23.2 million USD |
| 2021Q2 | -61.0 million USD | 22.4 million USD |
| 2021Q1 | -52.6 million USD | 20.0 million USD |
| 2020Q4 | -62.3 million USD | 20.6 million USD |
| 2020Q3 | -58.2 million USD | 20.0 million USD |
0J4V.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -182.0 million USD | 107.7 million USD |
| 2021 | -220.7 million USD | 86.3 million USD |
| 2020 | -227.3 million USD | 88.6 million USD |
| 2019 | -204.7 million USD | 146.0 million USD |
| 2018 | -178.8 million USD | 77.5 million USD |
| 2017 | -197.5 million USD | 30.8 million USD |
| 2016 | -173.1 million USD | 1.3 million USD |
0J4V.L
Price: $3.52
52 week price:
Earnings Per Share: -2.29 USD
P/E Ratio: -1.01
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 2.3 million